Trugman J, Finnegan M, Lipton R, et al. Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results from a Single Attack Phase II Study, ACHIEVE I. AAN 2018, emerging science abstract 008.
Onderliggende oorzaken TIA en minor stroke beïnvloeden risico ernstig vasculair event
dec 2023 | Atherosclerose, Neuro-vasculair